Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial

William D. Tap, Hans Gelderblom, Emanuela Palmerini, Jayesh Desai, Sebastian Bauer, Jean Yves Blay, Thierry Alcindor, Kristen Ganjoo, Javier Martín-Broto, Christopher W. Ryan, David M. Thomas, Charles Peterfy, John H. Healey, Michiel van de Sande, Heather L. Gelhorn, Dale E. Shuster, Q. Wang, Antoine Yver, Henry H. Hsu, Paul S. LinSandra Tong-Starksen, Silvia Stacchiotti, Andrew J. Wagner

    Research output: Contribution to journalArticlepeer-review

    55 Scopus citations

    Fingerprint Dive into the research topics of 'Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences